Dietary Supplementation with Inulin Modulates the Gut Microbiota and Improves Insulin Sensitivity in Prediabetes
Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modul...
Saved in:
Published in | International journal of endocrinology Vol. 2021; pp. 1 - 8 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Egypt
Hindawi
2021
John Wiley & Sons, Inc Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 1687-8337 1687-8345 |
DOI | 10.1155/2021/5579369 |
Cover
Loading…
Abstract | Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes. |
---|---|
AbstractList | Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m . After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, =0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, =0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, =0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, , , and both at 3 and 6 months, while with a decrease in the relative abundance of . Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes. Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6±6.9 years and BMI was 25.07±3.02kg/m[sup.2]. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38±0.50 vs. 2.22±0.62, P=0.03) and 2-hour post-OGTT insulin (4.01±0.77 vs. 3.74±0.76, P=0.02) and improved HOMA-IR (1.05±0.53 vs. 0.85±0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes. Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism. Methods. We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results. The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P = 0.03 ) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P = 0.02 ) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P = 0.03 ). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters. Conclusions. Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism.AIMSAccumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently reported to exert beneficial effects on the host metabolism. Here, we aimed to evaluate whether dietary supplementation with inulin modulates gut microbiota structure in prediabetes, affecting glucose and lipid metabolism.We performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene.METHODSWe performed a prospective single-arm study. A total of 49 subjects with prediabetes (WHO 1999 criteria) were voluntarily enrolled. Each subject received a daily supplement with 15 g of inulin for 6 months. Glucose and lipid metabolic parameters and gut microbiota were analyzed at baseline and at 3 and 6 months after inulin intervention. Intestinal microbiota profile was evaluated using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene.The mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters.RESULTSThe mean age of 49 subjects was 56.6 ± 6.9 years and BMI was 25.07 ± 3.02 kg/m2. After 24 weeks of prevention, inulin significantly decreased fasting insulin (2.38 ± 0.50 vs. 2.22 ± 0.62, P=0.03) and 2-hour post-OGTT insulin (4.01 ± 0.77 vs. 3.74 ± 0.76, P=0.02) and improved HOMA-IR (1.05 ± 0.53 vs. 0.85 ± 0.66, P=0.03). Gut microbiota analysis indicated that inulin supplement resulted in an increase in the relative abundance of Actinobacteria, Bifidobacteriales, Bifidobacteriaceae, Lactobacillaceae, Bifidobacterium, Lactobacillus, and Anaerostipes both at 3 and 6 months, while with a decrease in the relative abundance of Alistipes. Spearman correlation analysis revealed altered microbial community was associated with glucose and lipids metabolic parameters.Inulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes.CONCLUSIONSInulin supplementation improves insulin resistance of prediabetes and exerts beneficial effects on modulating the intestinal microbiota composition. These findings suggest that insulin may be a potentially novel and inexpensive intervention for prediabetes. |
Audience | Academic |
Author | Xu, Li Zhang, Qian Wang, Xiaojing Xiao, Xinhua Wang, Tong |
AuthorAffiliation | 1 Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 3 State Key Laboratory of Membrane Biology and Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China 2 Department of Endocrinology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China |
AuthorAffiliation_xml | – name: 3 State Key Laboratory of Membrane Biology and Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China – name: 1 Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China – name: 2 Department of Endocrinology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China |
Author_xml | – sequence: 1 givenname: Xiaojing surname: Wang fullname: Wang, Xiaojing organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn – sequence: 2 givenname: Tong surname: Wang fullname: Wang, Tong organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn – sequence: 3 givenname: Qian surname: Zhang fullname: Zhang, Qian organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn – sequence: 4 givenname: Li surname: Xu fullname: Xu, Li organization: State Key Laboratory of Membrane Biology and Tsinghua-Peking Center for Life SciencesSchool of Life SciencesTsinghua UniversityBeijingChinatsinghua.edu.cn – sequence: 5 givenname: Xinhua orcidid: 0000-0001-5441-7766 surname: Xiao fullname: Xiao, Xinhua organization: Department of EndocrinologyNHC Key Laboratory of EndocrinologyPeking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChinacacms.ac.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34257649$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk91v0zAQwCM0xD7gjWcUCQkhQTc78VdekKYBo9ImkAbPlmM7jafUDrHTaf8917WUdoIK5SGJ_bvf6ey74-zAB2-z7CVGpxhTelagAp9RyquSVU-yI8wEn4iS0IPNd8kPs-MYbxFijCH8LDssSUE5I9VR1n90NqnhPr8Z-76zc-uTSi74_M6lNp_6sXM-vw5m7FSyMU-tzS_HlF87PYTahaRy5U0-nfdDWMD-1MeHiBvro0tu4dJ9Dr_fBmucqi0onmdPG9VF-2L9Psl-fP70_eLL5Orr5fTi_GqiOUZpgkmDUCGU0YKzqm5oU_HGaMWUJhQzWjIs6toiVRS2YaJmtKamRobVpcEYs_Ikm668Jqhb2Q9uDlXKoJx8WAjDTKohOd1ZiQQinGtwMkEI1ZC1sVwRU3ENGw24Pqxc_VjPrdFwSIPqdqS7O961chYWUhQMY0FA8HYtGMLP0cYk5y5q23XK2zBGWVCKKSeMUEBfP0Jvwzh4OKolhTCnFed_qJmCApxvAuTVS6k8ZxUTkLis9lOipAJDDwB1-hcKHmPnTkOzNQ7Wd7T_F7CV4c1WQGtVl9oYunHZaHHXvB_cMr7avpHNVfxubADerwDo0xgH22wQjORybuRybuR6bgAvHuHarQYBSnPdv4LerYJa5426c_tT_AK8ZSOQ |
CitedBy_id | crossref_primary_10_1016_j_ijbiomac_2024_132735 crossref_primary_10_3390_nu16172935 crossref_primary_10_3390_nu16203447 crossref_primary_10_1111_1440_1681_13727 crossref_primary_10_3389_fmicb_2022_832151 crossref_primary_10_3389_fnut_2023_1108088 crossref_primary_10_3390_nu16030390 crossref_primary_10_1016_j_carbpol_2022_120422 crossref_primary_10_3389_fnut_2024_1520779 crossref_primary_10_20517_mrr_2023_79 crossref_primary_10_1038_s41467_023_43448_z crossref_primary_10_3390_foods12122367 crossref_primary_10_1017_S0007114524000904 |
Cites_doi | 10.1016/j.nut.2020.110854 10.1038/ismej.2009.112 10.1136/gutjnl-2012-303304 10.1038/nm.4517 10.3389/fendo.2019.00675 10.1053/j.gastro.2009.08.042 10.1038/nature11450 10.1097/cm9.0000000000000308 10.1038/ejcn.2016.156 10.1017/s0007114510003363 10.1079/nrr200479 10.1007/s00284-010-9582-9 10.1007/s00125-007-0791-0 10.1111/1574-6941.12228 10.1210/jc.2008-1348 10.1155/2020/8892176 10.1093/jn/125.6.1401 10.1177/1535370216654227 10.1007/s00125-018-4658-3 10.1038/s41574-019-0156-z 10.1136/gutjnl-2018-317609 10.1186/s12967-019-02159-0 10.1186/s12944-019-1167-4 10.1186/1475-2859-10-s1-s10 10.1136/gutjnl-2019-318424 10.1017/s095442241700018x 10.2337/dc18-s002 10.1186/s12933-021-01265-y 10.1017/s0007114510002874 10.1007/s00125-018-4550-1 10.1016/j.dsx.2018.07.016 10.1136/bmj.i5953 10.1136/gutjnl-2016-313271 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Xiaojing Wang et al. COPYRIGHT 2021 John Wiley & Sons, Inc. Copyright © 2021 Xiaojing Wang et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2021 Xiaojing Wang et al. 2021 |
Copyright_xml | – notice: Copyright © 2021 Xiaojing Wang et al. – notice: COPYRIGHT 2021 John Wiley & Sons, Inc. – notice: Copyright © 2021 Xiaojing Wang et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2021 Xiaojing Wang et al. 2021 |
DBID | RHU RHW RHX AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1155/2021/5579369 |
DatabaseName | Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central ProQuest Health & Medical Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1687-8345 |
Editor | naciu, Anda Mihaela |
Editor_xml | – sequence: 1 givenname: Anda Mihaela surname: naciu fullname: naciu, Anda Mihaela |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_080477c53668445c8adfe7a4d97c477f PMC8261184 A696882639 A683581649 34257649 10_1155_2021_5579369 |
Genre | Journal Article |
GeographicLocations | China Germany |
GeographicLocations_xml | – name: China – name: Germany |
GrantInformation_xml | – fundername: National Key R&D Program of China grantid: 2017YFC1309603; 2018YFC2001100 – fundername: Beijing Municipal Natural Science Foundation grantid: 7202163; 7214275 – fundername: National Natural Science Foundation of China grantid: 81170736; 81570715; 81870579; 82000746 |
GroupedDBID | --- 188 29J 2WC 4.4 53G 5GY 5VS 7X7 8FI 8FJ AAFWJ AAJEY AAWTL ABDBF ABUWG ACGFO ADBBV ADRAZ AEGXH AENEX AFKRA AFPKN AINHJ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU DIK E3Z EBD EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M48 O5R O5S OK1 PIMPY RHU RHW RHX RNS RPM TR2 TUS UKHRP ~8M 0R~ 24P AAYXX ACCMX ACUHS ALIPV CITATION H13 PGMZT PHGZM PHGZT 2UF C1A CEFSP CNMHZ EJD IL9 NPM UZ5 PMFND 3V. 7XB 8FK AAMMB AEFGJ AGXDD AIDQK AIDYY AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c710t-14f0028adc8769bf5f97fdca6ac451653618bbe0a22ef68b65b5db0d6b3d11163 |
IEDL.DBID | M48 |
ISSN | 1687-8337 |
IngestDate | Wed Aug 27 01:25:42 EDT 2025 Thu Aug 21 18:18:10 EDT 2025 Fri Jul 11 07:57:41 EDT 2025 Sat Aug 23 14:26:33 EDT 2025 Tue Jun 17 22:02:58 EDT 2025 Tue Jun 17 22:02:50 EDT 2025 Tue Jun 10 21:02:55 EDT 2025 Tue Jun 10 21:02:04 EDT 2025 Thu May 22 21:27:07 EDT 2025 Thu May 22 21:26:59 EDT 2025 Wed Feb 19 02:25:29 EST 2025 Tue Jul 01 03:54:37 EDT 2025 Thu Apr 24 23:08:21 EDT 2025 Sun Jun 02 18:54:51 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 Copyright © 2021 Xiaojing Wang et al. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c710t-14f0028adc8769bf5f97fdca6ac451653618bbe0a22ef68b65b5db0d6b3d11163 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Academic Editor: Anda Mihaela naciu |
ORCID | 0000-0001-5441-7766 |
OpenAccessLink | https://doaj.org/article/080477c53668445c8adfe7a4d97c477f |
PMID | 34257649 |
PQID | 2550175977 |
PQPubID | 4727234 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_080477c53668445c8adfe7a4d97c477f pubmedcentral_primary_oai_pubmedcentral_nih_gov_8261184 proquest_miscellaneous_2551574645 proquest_journals_2550175977 gale_infotracmisc_A696882639 gale_infotracmisc_A683581649 gale_infotracacademiconefile_A696882639 gale_infotracacademiconefile_A683581649 gale_healthsolutions_A696882639 gale_healthsolutions_A683581649 pubmed_primary_34257649 crossref_primary_10_1155_2021_5579369 crossref_citationtrail_10_1155_2021_5579369 hindawi_primary_10_1155_2021_5579369 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-00-00 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – year: 2021 text: 2021-00-00 |
PublicationDecade | 2020 |
PublicationPlace | Egypt |
PublicationPlace_xml | – name: Egypt – name: New York |
PublicationTitle | International journal of endocrinology |
PublicationTitleAlternate | Int J Endocrinol |
PublicationYear | 2021 |
Publisher | Hindawi John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: Hindawi – name: John Wiley & Sons, Inc – name: Wiley |
References | 22 23 24 25 26 L. Weglarz (31) 2003; 8 27 28 29 30 10 32 11 33 12 34 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 |
References_xml | – ident: 15 doi: 10.1016/j.nut.2020.110854 – ident: 34 doi: 10.1038/ismej.2009.112 – ident: 21 doi: 10.1136/gutjnl-2012-303304 – ident: 8 doi: 10.1038/nm.4517 – ident: 22 doi: 10.3389/fendo.2019.00675 – ident: 33 doi: 10.1053/j.gastro.2009.08.042 – ident: 27 doi: 10.1038/nature11450 – ident: 29 doi: 10.1097/cm9.0000000000000308 – ident: 13 doi: 10.1038/ejcn.2016.156 – ident: 14 doi: 10.1017/s0007114510003363 – volume: 8 start-page: 991 issue: 4 year: 2003 ident: 31 article-title: Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression publication-title: Cellular & Molecular Biology Letters – ident: 18 doi: 10.1079/nrr200479 – ident: 24 doi: 10.1007/s00284-010-9582-9 – ident: 26 doi: 10.1007/s00125-007-0791-0 – ident: 32 doi: 10.1111/1574-6941.12228 – ident: 3 doi: 10.1210/jc.2008-1348 – ident: 4 doi: 10.1155/2020/8892176 – ident: 11 doi: 10.1093/jn/125.6.1401 – ident: 2 doi: 10.1177/1535370216654227 – ident: 5 doi: 10.1007/s00125-018-4658-3 – ident: 9 doi: 10.1038/s41574-019-0156-z – ident: 30 doi: 10.1136/gutjnl-2018-317609 – ident: 17 doi: 10.1186/s12967-019-02159-0 – ident: 28 doi: 10.1186/s12944-019-1167-4 – ident: 12 doi: 10.1186/1475-2859-10-s1-s10 – ident: 19 doi: 10.1136/gutjnl-2019-318424 – ident: 25 doi: 10.1017/s095442241700018x – ident: 1 doi: 10.2337/dc18-s002 – ident: 7 doi: 10.1186/s12933-021-01265-y – ident: 23 doi: 10.1017/s0007114510002874 – ident: 10 doi: 10.1007/s00125-018-4550-1 – ident: 16 doi: 10.1016/j.dsx.2018.07.016 – ident: 6 doi: 10.1136/bmj.i5953 – ident: 20 doi: 10.1136/gutjnl-2016-313271 |
SSID | ssj0066601 |
Score | 2.3158784 |
Snippet | Aims. Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been... Accumulating evidence indicates gut microbiota dysbiosis is involved in metabolic disorders, including prediabetes. The prebiotic inulin has been frequently... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref hindawi |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1 |
SubjectTerms | Cholesterol Dextrose Diabetes Dietary supplements Endocrinology Feces Glucose Glucose tolerance tests Gut microbiota Hemoglobin Insulin Insulin resistance Intervention Lipids Metabolism Metabolites Microbiota Microbiota (Symbiotic organisms) Physiological aspects Plasma Prebiotics Prediabetic state Taxonomy Type 2 diabetes Variance analysis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQJCReEDA-AgWMNOABRWvqr-SxfIwNqQgJJu3N8le0SiOdulRo_z13dpItaFNfeGx9deK78_l-1_MdIXvSOO6FD7lhRuW8MjIvfVHmUoEzzkPN5QzvOy--y8Nj_u1EnFxr9YU5Yak8cGLcPng0XCknmJQl58KVxtdBGe4r5WCgRusLZ14PppINBp88Nj4uJGyhkjHVp7wLgWi_2BdCYSe70WEUa_YPlvnuKWLiP8ubPM9_EyivnUgHD8j9zpWk87SEh-ROaB6R3XkDMPr3JX1HY3JnjJrvkvPPy9Ca9SWNXTxTxjiKhGIclh41mI9OFyuPzbzCBQWvkH7dtHSxTHWaWkNN42mKQMD4Ucpgpz8x_T31n6Dw8cc69LHcx-T44MuvT4d512whd-BktHnBa8Rfxjuwj5WtRV2p2juDwhSFBP4XpbVhamazUMvSSmGFt1MvLfNgLyV7QnaaVROeEcqEARTmKm-85WbGS2aqKng-5Y4Jp1RGPvRc166rRI4NMc50RCRCaJSR7mSUkbcD9XmqwHEL3UcU4ECDdbPjF6BNutMmvU2bMvIaxa_TJdRh9-u5LLFQnOTV7RSVBLQCDl9G3kcKtBCwLGe6iw7AHKy1NZprG-XVnJMRJdgAN5roxuGrX-912ryFg5Ne1XVnyS40QE4w2lilMCNvhmF8AGbnNWG1iTSFUPgfeUaepp0xPIhFSIuvqEZ7ZiSn8UizPI11zuHdAf7y5_9DsC_IPVxqCp5NyE673oSX4E629lW0HH8BYYZt4Q priority: 102 providerName: Directory of Open Access Journals – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJCRe0GB8hBUw0oAHFNHUX8lj-RgdUhESTOqb5diOVmmkU5sK7b_nzk4yMjaNx8QXx_b5zvezz3eEHEpjuRPOp4YZlfLCyDR3WZ5KBcY49xWXE7zvPP8mZyf860Is2iBJm3-P8GG1Q3ievRdCYeq5HbIDEwxB-WzRKVwwwEOW40yCvOSMqc6__cq3g5UnBOjv1fDdUwTAv5fXmZlXvSX_Wn6O9sj91m6k08joB-SOrx-S_WkNmPnXBX1Dgydn2CLfJ-eflr4x6wsaUnZG93Acf4qbrvS4RudzOl85zNzlNxRMQPpl29D5MgZlagw1taNxuwHKj6O7Ov2Bvu4x2QSFx-9r323cPiInR59_fpylbWaF1IJF0aQZrxBsGWdBGRZlJapCVc4a5JzIpGAyy8vSj81k4iuZl1KUwpVjJ0vmQDlK9pjs1qvaPyWUCQOQyxbOuJKbCc-ZKQrv-JhbJqxSCXnXjbq2bdhxzH5xpgP8EEIjj3TLo4S87qnPY7iNG-g-IAN7GgySHV7AxNGtzGkwhrlSFnojc86Fhf5WXhnuCmWhoErIS2S_jjdOe1HXU5ljVDjJi5spCgnQBKy7hLwNFKgOoFvWtLcaYHAwsNagrtsoL-scDShB4O2gomuLL78-bGfzLSM46qa6btXWRgO-BA2NIQkT8qovxh-gK17tV9tAkwmFB-IJeRIlo_8RC_gVm6gGMjPg07CkXp6GoObQdsC6_Nn_tf6A3MPHuBc2IrvNeuufg3XYlC-CbvgDnfdbqA priority: 102 providerName: Hindawi Publishing – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELdgCIkXBAxYRgEjDXhA0Zr6K3lC5WNsSEVIMKlvkWM7rBIkXZsK7b_nznFSgjb2mPji2D7f5X6X8x0hB1IbboV1sWZaxTzTMk5tksZSgTHOXcnlBM87z77I41P-eS7mweG2DmGVnU70itrWBn3kh2D6wubBbGlvl-cxVo3Cv6uhhMZNcgtTlyH4UvMecIFl7ssfJxIEKWVMdYHvQiDmTw6FUFjPbvBJ8pn7e_18-wyR8e_FZfbnv2GUf32Xju6Ru8GgpNN2B9wnN1z1gOxOKwDTvy7oK-pDPL3vfJcsPyxco1cX1NfybOPGkTEUvbH0pMKodDqrLZb0cmsKtiH9tGnobNFma2o01ZWlrR8C2k_aOHb6DYPg2yoUFC6_rlzn0X1ITo8-fn9_HIeSC7EBU6OJE14iCtPWgJbMilKUmSqt0chSkUjBZJIWhRvrycSVMi2kKIQtxlYWzILWlOwR2anqyu0RyoQGLGYyq23B9YSnTGeZs3zMDRNGqYi86VY9NyEfOZbF-Jl7XCJEjjzKA48i8rKnXrZ5OK6ge4cM7Gkwe7a_Ua9-5EEYc7CSuVIGZiNTzoWB-ZZOaW4zZaChjMhzZH_eHkXtdUA-lSmmi5M8u5oik4BZwOyLyGtPgXoCpmV0OO4Ai4MZtwZ9XUe57XM0oARNYAYdXdq8ffog7OZrVnDUbfU86LN1vpW-iLzom_EFGKNXuXrjaRKh8E95RB63ktG_iHlgi0NUA5kZ8GnYUi3OfLZzGDuAYL7__2E9IXdwEq1zbER2mtXGPQVzsSmeeZ3wBxGaZeM priority: 102 providerName: ProQuest |
Title | Dietary Supplementation with Inulin Modulates the Gut Microbiota and Improves Insulin Sensitivity in Prediabetes |
URI | https://dx.doi.org/10.1155/2021/5579369 https://www.ncbi.nlm.nih.gov/pubmed/34257649 https://www.proquest.com/docview/2550175977 https://www.proquest.com/docview/2551574645 https://pubmed.ncbi.nlm.nih.gov/PMC8261184 https://doaj.org/article/080477c53668445c8adfe7a4d97c477f |
Volume | 2021 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELf2ISReEDA-AqUYacADCjSNP5IHhDrY1iF1mgaV8hY5tsMqjXR0qaD_PXfOx8jUsZdIrS9O7POd73c53xGyK5Rmhhvrq1BJn8VK-JEJIl9IMMaZzZkY4nnnybEYT9nXhCcbpKk2Wk_g5Vpoh_Wkpovz939-rT6BwH90As854vfgA-cSa9Ntkm3YkyQWcZiw9nsC2OiuEHIgQKSiMJRNCPy1uzubk8vh32rqO2eIkX_P1lmi1wMq_9mhDu6Te7VpSUfVWnhANmzxkOyMCoDVP1f0DXXBns6LvkMuvsxsqRYr6qp6VhHkyCKKfll6VGB8Op3MDRb3spcUrER6uCzpZFblbSoVVYWhlUcC2o-qiHb6DcPhq3oUFH6eLGzj231Epgf73z-P_br4gq_B6Cj9gOWIx5TRoC_jLOd5LHOjFTKXB4KHIoiyzA7UcGhzEWWCZ9xkAyOy0ID-FOFjslXMC_uU0JArQGU6NspkTA1ZFKo4toYNmA65ltIj75pZT3WdmRwLZJynDqFwniKP0ppHHnndUl9UGTluoNtDBrY0mEfb_TFf_EhrsUzBXmZSahiNiBjjGsabW6mYiaWGhtwjL5H9aXUotdUG6UhEmDhOsPhmilgAegED0CNvHQWuYRiWVvXBB5gczL3V6es2yqs-ex1K0Am609Ha5qu7d-vVfMsM9pqlnjaCmQIEBSWOWQs98qptxgdgtF5h50tHE3CJ38w98qSSjPZBoYO4-IqyIzMdPnVbitmZy3sO7w5wmD37_9ifk7s4iMpN1iNb5WJpX4DhWGZ9sikT2Sfbe_vHJ6d9536B62ES9J22gOvpOPkLTfRs2g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEIIXBIyPQGFG2uABRWsSfyQPCBXGaNk6IbFJfQuO7bBKkJZ-aOo_xd_InfNRgjb2tMfWF8f2nc_3u5zvCNkRSjPDjfVVpKTPEiX82ASxLyQY48zmTIR433l4LPqn7POIjzbI7_ouDIZV1jrRKWoz0egj3wPTF4QHs6W9m_7ysWoUfl2tS2iUYnFoV-cA2eZvB_vA390wPPh48qHvV1UFfA2n6cIPWI5AQxkNiiDJcp4nMjda4ah5IHgkgjjLbFeFoc1FnAmecZN1jcgiA4pBRNDvDXITDt4uhhDKUQPwAAm4csuBgI0bR5GsA-05Rx9DsMe5xPp5rSPQVQpozoNbZ4jEz8cX2bv_hm3-dQ4e3CN3KwOW9kqJu082bPGAbPUKAO8_V_QVdSGlzle_Rab7Y7tQsxV1tUPLOHUUBIreXzooMAqeDicGS4jZOQVblH5aLuhwXGaHWiiqCkNLvwe0D8q4efoVg-7LqhcUfn6Z2dqD_JCcXgszHpHNYlLYJ4RGXAH204lRJmMqZHGkksQa1mU64lpKj7ypVz3VVf5zLMPxI3U4iPMUeZRWPPLIbkM9LfN-XEL3HhnY0GC2bvfHZPY9rTZ_ClY5k1LDbETMGNcw39xKxUwiNTTkHtlG9qfl1ddG56Q9EWN6OsGSyykSARgJzEyPvHYUqJdgWlpV1ytgcTDDV6uvqyjXfXZalKB5dKujC5vXT-9U0nzFCnZqUU8r_TlP17vdIy-bZnwBxgQWdrJ0NAGX-GXeI4_LndG8KHJAGocoW3umxad2SzE-c9nVYewAutnT_w9rm9zunwyP0qPB8eEzcgcnVDrmOmRzMVva52CqLrIXTj9Q8u26FdIfoGqjJA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEIgXBIyPQGFG2uABRW0afyQPCBVKWRmdJsGkvmWO7bBKkJZ-aOq_xl_HnfNRgjb2tMfWF8f2nX--u5zvCNkTSjPDjfVVqKTPYiX8yASRLyQo48xmTHTxvvPoSBycsM9jPt4iv6u7MBhWWWGiA2oz1egjb4PqC8KD2dLaWRkWcdwfvJv98rGCFH5prcppFCJyaNfnYL4t3g77wOv9bnfw8duHA7-sMOBrOFmXfsAyNDqU0QAKcZrxLJaZ0QpnwAPBQxFEaWo7qtu1mYhSwVNu0o4RaWgAJEQI_d4gN2UIxybsJTmujT2wClzp5UDAJo7CUFZB95yjvyFocy6xll7jOHRVA-qz4dYZWuXnk4t0339DOP86Ewf3yN1SmaW9Qvruky2bPyA7vRwM-Z9r-oq68FLnt98hs_7ELtV8TV0d0SJmHYWCoieYDnOMiKejqcFyYnZBQS-ln1ZLOpoUmaKWiqrc0MIHAu3DIoaefsUA_KICBoWfx3NbeZMfkpNrYcYjsp1Pc_uE0JArsAN1bJRJmeqyKFRxbA3rMB1yLaVH3lSrnugyFzqW5PiROJuI8wR5lJQ88sh-TT0rcoBcQvceGVjTYOZu98d0_j0pgSABDZ1JqWE2ImKMa5hvZqViJpYaGjKP7CL7k-IabI0_SU9EmKpOsPhyiliAvQQqp0deOwrEKJiWVuVVC1gczPbV6Osqyk2frQYloJBudHRh8-bpvVKar1jBViXqSYmli2Sz8z3ysm7GF2B8YG6nK0cTcIlf6T3yuNgZ9YtCZ1TjEGVjzzT41GzJJ2cu0zqMHQxw9vT_w9oltwGKki_Do8Nn5A7Op_DRtcj2cr6yz0FrXaYvHDxQcnrdePQHjRGnWg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dietary+Supplementation+with+Inulin+Modulates+the+Gut+Microbiota+and+Improves+Insulin+Sensitivity+in+Prediabetes&rft.jtitle=International+journal+of+endocrinology&rft.au=Wang%2C+Xiaojing&rft.au=Wang%2C+Tong&rft.au=Zhang%2C+Qian&rft.au=Xu%2C+Li&rft.date=2021&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1687-8337&rft.volume=2021&rft_id=info:doi/10.1155%2F2021%2F5579369&rft.externalDocID=A683581649 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1687-8337&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1687-8337&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1687-8337&client=summon |